Robert Azelby

Companies

• Tango Therapeutics (United States)Board member Jun 23, 2026 to now¹
• Autolus TherapeuticsBoard member Mar 18, 2026 to now²
• Terns Pharmaceuticals, Inc.Board member Feb 24, 2025 to now³
• Cardinal HealthBoard member Mar 1, 2024 to now⁴
• ADC Therapeutics SABoard member Jan 2, 2024 to now⁵
• CHINOOK THERAPEUTICS, INC.Board member Apr 12, 2023 to Aug 11, 2023⁶
• Climb Bio, Inc.President Jan 31, 2022 to Nov 2, 2022⁷
• Climb Bio, Inc.Board member Aug 9, 2021 to Nov 2, 2022⁸
• Climb Bio, Inc.Chief executive officer Aug 9, 2021 to Nov 2, 2022⁸
• Clovis OncologyBoard member Oct 12, 2018 to Jun 11, 2021⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Cardinal Health CAH4,085 shares¹⁰$1.0M at $256.86Nov 5, 2025
• ATADC Therapeutics SA ADCT112,805 shares¹¹$166.4K at $1.47Jun 3, 2026
• TTTango Therapeutics (United States) TNGX5,740 shares¹²$136.3K at $23.74Jun 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 19, 2026Granted 5,740 shares of Tango Therapeutics (United States)¹²
• Jun 3, 2026Shares withheld for tax 12,600 shares at $3.08 of ADC Therapeutics SA¹¹
• Jun 1, 2026Granted 45,000 shares of ADC Therapeutics SA¹¹
• Nov 5, 2025Granted 1,067 shares of Cardinal Health¹⁰
• Jun 13, 2025Shares withheld for tax 12,600 shares at $3.58 of ADC Therapeutics SA¹³
• Jun 3, 2025Granted 40,000 shares of ADC Therapeutics SA¹⁴
• Nov 6, 2024Granted 1,730 shares of Cardinal Health¹⁵
• Jun 17, 2024Sold 6,995 shares at $2.89 of ADC Therapeutics SA¹⁶
• Jun 13, 2024Granted 40,000 shares of ADC Therapeutics SA¹⁷
• Mar 15, 2024Granted 1,288 shares of Cardinal Health¹⁸